Avsnitt
-
Guest: Atul A. Deodhar, MD, MRCP
Based on data from 25 studies, ixekizumab has a lower risk of common adverse events like depression, cardiovascular events, cancer, and uveitis that are often seen with other treatments for psoriasis, psoriatic arthritis, and axial spondyloarthritis. Here to share the safety findings on ixekizumab is Dr. Atul Deodhar, Professor of Medicine and the Medical Director of Rheumatology Clinics at Oregon Health & Science University
-
Guest: Vernon K. Sondak, MD
Melanoma treatment has undergone a rapid evolution. Immunotherapy has doubled survival rates, and timing the use of these drugs around surgery has shown to be even more effective. Dr. Vernon Sondak explores how the fight against melanoma is stronger than ever with new therapeutic combinations and evolving treatment strategies. Dr. Sondak is the Chair of the Department of Cutaneous Oncology at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida.
-
Saknas det avsnitt?
-
Guest: Katrina Abuabara, MD, FAAD
Phototherapy, biologics, and JAK inhibitors can all play a role in atopic dermatitis treatment, but it’s essential to consider patient-specific factors before choosing one of these options. Dr. Katrina Abuabara, Associate Professor of Dermatology at the University of California, San Francisco School of Medicine, explains how we should approach these decisions when caring for patients with atopic dermatitis. Dr. Abuabara also spoke on this topic at the 2025 American Academy of Dermatology Annual Meeting.
-
Guest: Maria Hordinsky, MD, FAAD
From clinical research to direct patient care, dermatology tools powered by artificial intelligence (AI) present a new approach to hair loss treatment. Dr. Maria Hordinsky explains how virtual tattoo technology and at-home devices now provide measurable data, improving patient outcomes and allowing dermatologists to personalize treatment with precision. Dr. Hordinsky is the R. W. Goltz Professor and Vice Chair of Research in the Department of Dermatology at the University of Minnesota, and she spoke about this topic at the 2025 American Academy of Dermatology National Meeting.
-
Guest: Maria Hordinsky, MD, FAAD
Artificial intelligence (AI) is reshaping dermatology care, but integrating it into clinical practice comes with challenges. Dr. Maria Hordinsky explores how clinics must adapt workflows and invest in new technologies to fully harness the potential for AI to drive better hair loss treatment. Dr. Hordinsky is the R. W. Goltz Professor and Vice Chair of Research in the Department of Dermatology at the University of Minnesota.
-
Guest: Eva Parker, MD, FAAD
Rising temperatures, worsening air quality, and extreme weather events appear to be increasing the prevalence and severity of skin diseases. Dr. Eva Parker, Assistant Professor of Dermatology and Core Faculty at the Center for Biomedical Ethics and Society at Vanderbilt University Medical Center, shares strategies for dermatologists to improve climate literacy, reduce their carbon footprint, and educate patients on protecting their skin against climate-related impacts.
-
Guest: Shari Lipner, MD
Nail psoriasis requires a patient-centric approach that balances targeted treatments with realistic expectations. Dr. Shari Lipner shares expert insights on intralesional steroids, topical therapies, and advanced systemic options to manage this challenging condition. Dr. Lipner is an Associate Professor of Clinical Dermatology and the Director of the Nail Center at Weill Cornell Medicine.
-
Guest: Shari Lipner, MD
A combination of clinical evaluation, histopathology, and emerging imaging techniques can help diagnose nail psoriasis. Hear from Dr. Shari Lipner, Associate Professor of Clinical Dermatology at Weill Cornell Medicine, as she explains common characteristics of nail psoriasis and best practices for diagnosing it and distinguishing it from similar diseases.
-
Guest: Atul A. Deodhar, MD, MRCP
Despite feeling some symptom relief with treatment, patients with psoriasis, psoriatic arthritis, and axial spondyloarthritis often experience persistent unmet needs. Residual pain, fatigue, and uncertainty about whether current therapies alter disease progression and outcomes are a few of the challenges that remain unaddressed, emphasizing the need for improved understanding and management of these conditions. Learn about how these difficulties impact patients with Dr. Atul Deodhar, Professor of Medicine and Medical Director of Rheumatology Clinics at Oregon Health & Science University.
-
Host: Brian P. McDonough, MD, FAAFP
Guest: Holly S. Greenwald, MD
Misconceptions around irritable bowel syndrome with diarrhea (IBS-D) can contribute to significant gaps in care and unmet patient needs. Primary care providers play a crucial role in addressing these needs and ensuring an accurate diagnosis. To learn more about best practices for diagnosing and communicating with patients, Dr. Brian McDonough sits down with Dr. Holly Greenwald, Assistant Professor of Clinical Medicine at Temple University Lewis Katz School of Medicine.
Salix Pharmaceuticals
400 Somerset Corporate Blvd.
Bridgewater, NJ 08807
© 2025 Salix Pharmaceuticals or its affiliates. MED-US-NPR-0048 -
Host: Brian P. McDonough, MD, FAAFP
Guest: Paul P. Doghramji, MD, FAAFP
For patients with IBS-D, the stigma surrounding the condition can make it difficult to openly discuss their symptoms and accept their diagnosis. Providing reassurance and a clear path forward can help create a supportive and comfortable environment for these patients. To learn more about how we can destigmatize IBS-D, Dr. Brian McDonough sits down with Dr. Paul Doghramji, who’s the Medical Director of Health Services at Ursinus College and a physician at Collegeville Family Practice and Pottstown Memorial Medical Center.
Salix Pharmaceuticals
400 Somerset Corporate Blvd.
Bridgewater, NJ 08807
© 2025 Salix Pharmaceuticals or its affiliates. MED-US-NPR-0053 -
Guest: Robert Gniadecki, MD
For patients with psoriasis, the most effective therapy is not always accessible. Considering patient-specific factors, including overall health, can help create a holistic treatment plan. Tune in to hear from Dr. Robert Gniadecki, Professor and Director of the Division of Dermatology at the University of Alberta, as he discusses best practices for tailoring psoriasis management.
-
Guest: Daniel M. Klufas, MD
For patients with hidradenitis suppurativa, treatment varies by stage. Topicals, antibiotics, biologics, and procedural interventions can all play a role in management depending on symptoms and severity. Learn more as Dr. Daniel Klufas, an Assistant Professor of Dermatology at the University of California, San Francisco discusses current options and best practices for optimal care.
-
Guest: Daniel M. Klufas, MD
Early diagnosis and prompt intervention in hidradenitis suppurativa patients are essential to preventing long-term impacts. With emerging treatments on the horizon, the future of hidradenitis suppurativa care is promising. Dr. Daniel Klufas, an Assistant Professor of Dermatology at the University of California, San Francisco, provides insight into the future of diagnosis and treatment.
-
Guest: Daniel M. Klufas, MD
Hidradenitis suppurativa is a chronic skin condition characterized by painful abscesses, sinus tracts, and immune dysregulation. Dr. Daniel Klufas, an Assistant Professor of Dermatology at the University of California, San Francisco, explains the symptoms, impacts, and unmet needs associated with the disease.
-
Host: Raj Chovatiya, MD, PhD
Guest: Jeff Yu, MD, MS
Chronic hand eczema (CHE) can have vast impacts on a patient’s personal and professional life, making the overall patient journey one of the most important considerations for clinicians. That’s why Dr. Jeff Yu joins Dr. Raj Chovatiya to share best practices for diagnosing and treating patients with CHE so we can optimize their journey. Dr. Yu is an Associate Professor at the Rosalind Franklin University Chicago Medical School.
-
Host: Raj Chovatiya, MD, PhD
Guest: Benjamin Ehst, MD, PhD
The underlying mechanisms behind chronic hand eczema (CHE) can lead to a variety of physical, emotional, social, and occupational challenges. To learn more about these challenges, Dr. Raj Chovatiya sits down with Dr. Benjamin Ehst to discuss what we currently know about the pathophysiology of CHE and what we can do to address patients’ unmet needs. Dr. Ehst is a dermatologist at Broadway Medical Clinic and an investigator at the Oregon Medical Research Center.
-
Host: Raj Chovatiya, MD, PhD
Here to share his insights on the key themes and topics covered at the Maui Derm 2025 conference is Dr. Raj Chovatiya. Dr. Chovatiya is a Clinical Associate Professor at the Rosalind Franklin University Chicago Medical School and Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago.
-
Host: Raj Chovatiya, MD, PhD
Here to share a glimpse into where the dermatology field might be headed based on updates from the Maui Derm 2025 conference is Dr. Raj Chovatiya. Dr. Chovatiya is a Clinical Associate Professor at the Rosalind Franklin University Chicago Medical School and Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago.
-
Host: Raj Chovatiya, MD, PhD
How should we approach caring for undifferentiated eczema patients who didn’t have eczema as a child, who doesn’t have atopic co-morbidities, and isn’t flexural? Here to give a quick overview of his session at the Maui Derm 2025 conference that sought to help answer this question is Dr. Raj Chovatiya. Dr. Chovatiya is a Clinical Associate Professor at the Rosalind Franklin University Chicago Medical School and Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago.
- Visa fler
